High Court Should Review Horizon Arthritis Drug Patent Case

So much patent-law attention today focuses on Title 35 of the U.S. Code, Section 101, and the ever-emerging ineligibility case law, and perhaps rightly so. The problem arises when another legal...

Already a subscriber? Click here to view full article